Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/MariMed Inc.
Company profile

MariMed Inc.

OTC: MRMD · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Norwood, MA · NorfolkCIK 0001522767Reports USD
#303 of 1,394 Healthcare companies by revenue44th-percentile growth
EA Score
66B
FH 62DQ 81GM 49SS 66
v0.1 · 65/100 weight · provisional
↑ disclosure history, workforce scale · ↓ revenue growth (YoY), balance-sheet leverage
Methodology →
Revenue TTM
$161.5M
Rev growth YoY (TTM)
+2.2%
Net income (FY)
-$14.5M
Employees
715
Market cap
$27.2M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$159.8M$159.8M2025
Net income-$14.5M-$14.5M2025
Operating income-$2.8M-$2.8M2025
Total assets$202.6M$202.6M2025
Liabilities$137.8M$137.8M2025
Equity$50.0M$50.0M2025

Revenue trend

FY2018 – FY2025 · USD
$11.9M
FY18
$16.6M
FY19
$50.9M
FY20
$121.5M
FY21
$134.0M
FY22
$148.6M
FY23
$158.0M
FY24
$159.8M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product Sales56%
Product Sales - Wholesale44%
Other1%
By geography

Not disclosed.

The read

MariMed Inc. booked $159.8M in FY2025 revenue, growing 1.2% year over year — about the middle of the pack among Healthcare companies we track, at a -9.1% net margin.

Peers · Healthcare
Rein Therapeutics Inc.36DHarvard Bioscience, Inc.58CPositron Corporation28DiBio, Inc.49D
Neighbors
Norfolk →
SharkNinja, Inc.$6.4B56CTripadvisor, Inc.$1.9B74BNB Bancorp, Inc. Common Stock——Candel Therapeutics, Inc.$125.0k32DVerastem, Inc.$30.9M48DJ.Jill, Inc.$596.5M53D
Key facts
CEOJon R. Levine
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersNorwood, MA
ExchangeOTC: MRMD
Employees715
IPO date2012-08-03
Latest filings
8-K2026-06-0810-Q2026-05-148-K2026-05-13DEF 14A2026-04-2310-K2026-03-128-K2026-03-118-K2026-03-0210-Q2025-11-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies